Overview
Vitalograph makes and supplies devices for respiratory testing, such as spirometers, lung and asthma monitors, COPD screeners, medical workstations, software and consumables used by clinicians and occupational health professionals around the world. Spirometers and related devices collect lung-function data during tests, and accompanying software analyzes results to provide clear outputs that support diagnosis, monitoring and management of respiratory conditions. The company differentiates itself through its long specialization in spirometry, a global presence and a history of clinical trials with major pharma and CROs, plus an integrated hardware-software ecosystem that emphasizes accurate data and usable outputs for clinicians. Its goal is to improve patient lives by delivering accurate, high-quality devices and services that advance cardiorespiratory care worldwide.
Work here?Claim your company
Simplify's take
What believers are saying
- November 5, 2026 rebrand unified Morgan Scientific under Vitalograph, simplifying North American selling.
- US PFT sales nearly doubled since 2024, showing strong demand momentum.
- July 2026 Lenexa operations center improves QC, distribution, and Canadian delivery.
What critics are saying
- Vitalograph's growth depends on respiratory testing budgets; trial delays quickly hit Elevate adoption.
- Competing platforms from Vyaire, Nihon Kohden, and local labs pressure pricing and margins.
- If regulators or hospitals reject digital endpoints, Vitalograph's software thesis stalls entirely.
What makes Vitalograph unique
- Vitalograph owns devices, software, and endpoint workflows across healthcare and clinical trials.
- 60 years of respiratory diagnostics expertise powers Vitalograph's integrated comPAS and Elevate stack.
- Global manufacturing in Ennis and US operations in Lenexa support tighter supply control.
Help us improve and share your feedback! Did you find this helpful?